These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 26949165)

  • 1. Rational engineering of single-chain polypeptides into protein-only, BBB-targeted nanoparticles.
    Serna N; Céspedes MV; Saccardo P; Xu Z; Unzueta U; Álamo P; Pesarrodona M; Sánchez-Chardi A; Roldán M; Mangues R; Vázquez E; Villaverde A; Ferrer-Miralles N
    Nanomedicine; 2016 Jul; 12(5):1241-51. PubMed ID: 26949165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LDLR-mediated peptide-22-conjugated nanoparticles for dual-targeting therapy of brain glioma.
    Zhang B; Sun X; Mei H; Wang Y; Liao Z; Chen J; Zhang Q; Hu Y; Pang Z; Jiang X
    Biomaterials; 2013 Dec; 34(36):9171-82. PubMed ID: 24008043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo architectonic stability of fully de novo designed protein-only nanoparticles.
    Céspedes MV; Unzueta U; Tatkiewicz W; Sánchez-Chardi A; Conchillo-Solé O; Álamo P; Xu Z; Casanova I; Corchero JL; Pesarrodona M; Cedano J; Daura X; Ratera I; Veciana J; Ferrer-Miralles N; Vazquez E; Villaverde A; Mangues R
    ACS Nano; 2014 May; 8(5):4166-76. PubMed ID: 24708510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of LDL receptor-targeting peptide vectors for
    Molino Y; David M; Varini K; Jabès F; Gaudin N; Fortoul A; Bakloul K; Masse M; Bernard A; Drobecq L; Lécorché P; Temsamani J; Jacquot G; Khrestchatisky M
    FASEB J; 2017 May; 31(5):1807-1827. PubMed ID: 28108572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The targeted delivery of cancer drugs across the blood-brain barrier: chemical modifications of drugs or drug-nanoparticles?
    Juillerat-Jeanneret L
    Drug Discov Today; 2008 Dec; 13(23-24):1099-106. PubMed ID: 18848640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel functionalization strategies of polymeric nanoparticles as carriers for brain medications.
    Portioli C; Bovi M; Benati D; Donini M; Perduca M; Romeo A; Dusi S; Monaco HL; Bentivoglio M
    J Biomed Mater Res A; 2017 Mar; 105(3):847-858. PubMed ID: 27885823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier.
    Tosi G; Fano RA; Bondioli L; Badiali L; Benassi R; Rivasi F; Ruozi B; Forni F; Vandelli MA
    Nanomedicine (Lond); 2011 Apr; 6(3):423-36. PubMed ID: 21542682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An in vitro and in vivo study of peptide-functionalized nanoparticles for brain targeting: The importance of selective blood-brain barrier uptake.
    Bode GH; Coué G; Freese C; Pickl KE; Sanchez-Purrà M; Albaiges B; Borrós S; van Winden EC; Tziveleka LA; Sideratou Z; Engbersen JFJ; Singh S; Albrecht K; Groll J; Möller M; Pötgens AJG; Schmitz C; Fröhlich E; Grandfils C; Sinner FM; Kirkpatrick CJ; Steinbusch HWM; Frank HG; Unger RE; Martinez-Martinez P
    Nanomedicine; 2017 Apr; 13(3):1289-1300. PubMed ID: 27884636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery to the CNS and polymeric nanoparticulate carriers.
    Costantino L
    Future Med Chem; 2010 Nov; 2(11):1681-701. PubMed ID: 21428839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivery of analgesic peptides to the brain by nano-sized bolaamphiphilic vesicles made of monolayer membranes.
    Popov M; Abu Hammad I; Bachar T; Grinberg S; Linder C; Stepensky D; Heldman E
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):381-9. PubMed ID: 23791683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic delivery of blood-brain barrier-targeted polymeric nanoparticles enhances delivery to brain tissue.
    Saucier-Sawyer JK; Deng Y; Seo YE; Cheng CJ; Zhang J; Quijano E; Saltzman WM
    J Drug Target; 2015; 23(7-8):736-49. PubMed ID: 26453169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS.
    Peluffo H; Unzueta U; Negro-Demontel ML; Xu Z; Váquez E; Ferrer-Miralles N; Villaverde A
    Biotechnol Adv; 2015; 33(2):277-87. PubMed ID: 25698504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategies for transporting nanoparticles across the blood-brain barrier.
    Zhang TT; Li W; Meng G; Wang P; Liao W
    Biomater Sci; 2016 Feb; 4(2):219-29. PubMed ID: 26646694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and functional features of self-assembling protein nanoparticles produced in endotoxin-free Escherichia coli.
    Rueda F; Céspedes MV; Sánchez-Chardi A; Seras-Franzoso J; Pesarrodona M; Ferrer-Miralles N; Vázquez E; Rinas U; Unzueta U; Mamat U; Mangues R; García-Fruitós E; Villaverde A
    Microb Cell Fact; 2016 Apr; 15():59. PubMed ID: 27059706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene delivery targeted to the brain using an Angiopep-conjugated polyethyleneglycol-modified polyamidoamine dendrimer.
    Ke W; Shao K; Huang R; Han L; Liu Y; Li J; Kuang Y; Ye L; Lou J; Jiang C
    Biomaterials; 2009 Dec; 30(36):6976-85. PubMed ID: 19765819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy.
    Ferrer-Miralles N; Rodríguez-Carmona E; Corchero JL; García-Fruitós E; Vázquez E; Villaverde A
    Crit Rev Biotechnol; 2015 Jun; 35(2):209-21. PubMed ID: 24102113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted drug delivery system to neural cells utilizes the nicotinic acetylcholine receptor.
    Huey R; O'Hagan B; McCarron P; Hawthorne S
    Int J Pharm; 2017 Jun; 525(1):12-20. PubMed ID: 28412449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current strategies for targeted delivery of bio-active drug molecules in the treatment of brain tumor.
    Garg T; Bhandari S; Rath G; Goyal AK
    J Drug Target; 2015 Dec; 23(10):865-87. PubMed ID: 25835469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delivery of a peptide-drug conjugate targeting the blood brain barrier improved the efficacy of paclitaxel against glioma.
    Li Y; Zheng X; Gong M; Zhang J
    Oncotarget; 2016 Nov; 7(48):79401-79407. PubMed ID: 27765902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiopep-conjugated poly(ethylene glycol)-co-poly(ε-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma.
    Xin H; Jiang X; Gu J; Sha X; Chen L; Law K; Chen Y; Wang X; Jiang Y; Fang X
    Biomaterials; 2011 Jun; 32(18):4293-305. PubMed ID: 21427009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.